<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04413747</url>
  </required_header>
  <id_info>
    <org_study_id>2020_COVID19_YOGA</org_study_id>
    <secondary_id>2020-001731-28</secondary_id>
    <nct_id>NCT04413747</nct_id>
  </id_info>
  <brief_title>Yoga Pranayama Adjuvant to Treat Burden COVID -19</brief_title>
  <acronym>YOCO</acronym>
  <official_title>Yoga- Based Breathing for Vagus Nerve Stimulation as Home-care Adjuvant Treatment Against Burden COVID 19 Outbreak</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Health Ricerca e Sviluppo S.R.L.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Swami Vivekananda Yoga Anusandhana Samsthana, Bangaluru , India</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Yoga Experience Association,Cervia (Ra), Italy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>EJTN GEIE, Brussellese, Belgium</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Casa di Riposo e Ambulatorio Giardino St Lucia, Massa Lomabarda (Ra) Italy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Halnet Srl, Faenza (Ra), Italy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Health Ricerca e Sviluppo S.R.L.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      COronaVIrus Disease 19 or SARS-CoV-2 (COVID-19) mortality occurs mainly from immunological
      behavior or by suicide after healing . In both cases, the causal link is coronavirus within
      the host response. The rationale of use of deep yoga breathing as adjuvant treatment to
      COVID-19 disease , is linked to the mechanical action to stimulate the vagus nerve through
      scalene and sternocleidomastoid muscles function of which the continuity of action bring to
      modulate upto suppress, the inflammatory reflex and pro-inflammatory cytokines overproduction
      and contextual lowering of the sympathetic stress response as a first cause of sleep and late
      mental disorders which can increase the annual suicide rate. An easily breathing medical Yoga
      protocol has been developed to test a cost-effective care provision, training, contact
      tracing and mass efficacy testing.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      COronaVIrus Disease 19 or SARS-CoV-2 (COVID-19) pandemic threatens patients, societies and
      healthcare systems around the world. Morbidity and lethality have a direct link with the
      early vicious circles triggered by an acute microcirculation endotheliopathy, a correlated
      coagulopathy, up to late hypoxic damage of multi organ tissue The host immunity determines
      the progress of the disease , its lethality and the need of care intensity. The clinical
      course of the infection consist of three stage of which only the third -which intervenes in a
      low incidence of patients - need of hospitalization for severe hyperinflammatory syndrome
      including acute respiratory failure, while first and the second or moderate pulmonary
      involvement, might manage and monitoring within a homecare program during quarantine.
      Actually, the rough mortality in Italy is - at the current date - 7.6 % with an expected
      death of 0.004 of the whole population. The late lethality - still little known - from
      COVID-19 is to be correlated with mental disorders from stress response emerging from the
      first three COVID-19's stages and which result in a significant increase in suicides that is
      estimated at 30% more than expected of 7.4 deaths for 100,000 residents. This estimate can be
      considered as stage 4 of the disease or post COVID-19 mortality. In this scenario, mortality
      of COVID -19 is by intensity response of &quot;the host &quot; and in the meantime, a cutoff for
      homecare, hospitalization and time-related stress disease. Lines of evidence reports that
      direct-indirect stimulation of vagus nerve bring to the modulating of pro-inflammatory
      cytokines with effective systemic anti-inflammatory effect and has shown antidepressant
      effects in chronic treatment resistant depression. Because the vagus nerve is linked to brain
      regions important in anxiety regulation (locus coeruleus, orbitofrontal cortex, insula,
      hippocampus and amygdala), this pathway is involved in perceiving various somatic and
      cognitive symptoms that characterize anxiety and mental disorder disorders. On the basis of
      all these reasoning we plan to introduce a medical based-yoga deep breathing for activation
      of vagus nerve by scalene and sternocleidomastoid muscles function during breathing, as an
      adjuvant of care of the 1-2 and 4 stages of the COVID-19 disease to counteract the cumulative
      incidence of mortality and better outcome. Medical yoga protocol has been developed and
      designed to test a cost-effective care provision, training, contact tracing and mass efficacy
      testing.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2020</start_date>
  <completion_date type="Anticipated">September 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Model- based adjusted outcome via hierarchical comparison of control curves using COVID-19 epidemic data with cyber layer alghorithm of population</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Data analysis by an independent governmental group for epidemiological studies of the National Research Council with data extracted only for ID on and CRF</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>12 months</time_frame>
    <description>COVID-19's Patients mortality all cause incidence proportion</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mortality-suicide</measure>
    <time_frame>12 months</time_frame>
    <description>COVID-19's Patients suicide rate</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Need of hospitalization for respiratory failure of COVID19's Patients</measure>
    <time_frame>12 months</time_frame>
    <description>In-hospital COVID-19's Patients oxygen use, invasive ventilation or high flow oxygen devices incidence proportion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Homecare professional psychiatric-psychological interventions for COVID-19's Patients</measure>
    <time_frame>12 months</time_frame>
    <description>At home or telematic incidence proportion of professional psychiatric-psychological interventions for anxiety and depression</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep disturbances of COVID-19's Patients as mental disorder</measure>
    <time_frame>12 months</time_frame>
    <description>Rate of positive scores for depression and anxiety according to the Pittsburgh Sleep Quality Index (PSQI) requiring drug treatment</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Coronavirus Infection</condition>
  <condition>Cytokine Storm</condition>
  <condition>Mental Disorder</condition>
  <arm_group>
    <arm_group_label>YOGA BREATHING</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Three daily yoga pranayama breathing cycles within existing home-care provision of Covid-19's patients (protocols shared dated 27 March 2020 by Italian Society of Infectious and Tropical Diseases - Italian General Practitioners Physician - Italian Society of General Medicine, Italy)</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>morning pranayama</intervention_name>
    <description>Low and deep inspiration and OM laryngeal vibration as expiratory exercises, sitting in easy pose. . The length of more than 5 -8 sec. and frequency between 20 and 23 breaths /min. Conscious breath number (n°) of 15 respiratory acts (RAc) and OM pranayama Technique n° of 5 RAc and Bhramari pranayama n° of 5 RAc</description>
    <arm_group_label>YOGA BREATHING</arm_group_label>
    <other_name>First procedure</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>pre_lunch pranayama</intervention_name>
    <description>Low and deep inspiration and OM laryngeal vibration as expiratory exercises, sitting in easy pose. . The length of more than 5 -8 sec. and frequency between 20 and 23 breaths /min. Conscious breath number (n°) of 15 respiratory acts (RAc) and OM pranyama Technique n° of 5 RAc and Surya Bheda pranayama n° of 5 RAc</description>
    <arm_group_label>YOGA BREATHING</arm_group_label>
    <other_name>Second procedure</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>pre_dinner pranayama</intervention_name>
    <description>Low and deep inspiration and OM laryngeal vibration as expiratory exercises, sitting in easy pose. . The length of more than 5 -8 sec. and frequency between 20 and 23 breaths /min. Conscious breath number (n°) of 15 respiratory acts (RAc) and OM pranayama Technique n° of 5 RAc and Nadi Shodhana pranayama n° of 5 RAc</description>
    <arm_group_label>YOGA BREATHING</arm_group_label>
    <other_name>Third procedure</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥ 18 &lt; 75 yr;

          -  Gender: both;

          -  COVID-19 positive: disease stage I-II (initial); Stage IV (post acute).

        Exclusion Criteria:

          -  Any patient aged or apparently aged less than 18 years and over 75 yr;

          -  Any patients Stage III COVID-19 infection acute phase with respiratory failure;

          -  Any female patient known to be or apparently pregnant;

          -  Participation in other interventional trials;

          -  Malignant primary disease as a cause of SIRS or sepsis.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nagarathna Raghuram, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vivekananda Yoga Anusandhana Samsthana, Bengaluru, India</affiliation>
  </overall_official>
  <overall_official>
    <last_name>HR Nagendra., Eng</last_name>
    <role>Study Chair</role>
    <affiliation>Vivekananda Yoga Anusandhana Samsthana, Bengaluru, India</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maria Donatella Barbagallo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yoga Experience Association,Cervia (Ra), Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Enrico Ricci, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yoga Experience Association,Cervia (Ra), Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Morena Gaddoni, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Casa di Riposo Giardino St Lucia, Massa Lombarda (Ra) Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maria Luisa Vitobello</last_name>
    <role>Study Director</role>
    <affiliation>EJTN GEIE, Brussellese, Belgium</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Luca Ghetti, Eng.</last_name>
    <role>Study Director</role>
    <affiliation>Halnet Srl</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Giorgio Noera, MD, PhD</last_name>
    <phone>+393358294727</phone>
    <email>presidenza@healthricercaesviluppo.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Boris Bazzani, ERYT</last_name>
    <phone>+393384841931</phone>
    <email>amministrazione@fbiteam.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ambulatorio Telemedicina Giardino St Lucia</name>
      <address>
        <city>Massa Lombarda</city>
        <state>Ravenna</state>
        <zip>48024</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Morena Gaddoni</last_name>
      <phone>+39054581871</phone>
      <email>direzione@giardinostlucia.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Wenham C, Smith J, Morgan R; Gender and COVID-19 Working Group. COVID-19: the gendered impacts of the outbreak. Lancet. 2020 Mar 14;395(10227):846-848. doi: 10.1016/S0140-6736(20)30526-2. Epub 2020 Mar 6.</citation>
    <PMID>32151325</PMID>
  </reference>
  <reference>
    <citation>Johansson PI, Stensballe J, Ostrowski SR. Shock induced endotheliopathy (SHINE) in acute critical illness - a unifying pathophysiologic mechanism. Crit Care. 2017 Feb 9;21(1):25. doi: 10.1186/s13054-017-1605-5. Review. Erratum in: Crit Care. 2017 Jul 13;21(1):187.</citation>
    <PMID>28179016</PMID>
  </reference>
  <reference>
    <citation>Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, Wang H, Abumrad N, Eaton JW, Tracey KJ. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature. 2000 May 25;405(6785):458-62.</citation>
    <PMID>10839541</PMID>
  </reference>
  <reference>
    <citation>Koopman FA, Chavan SS, Miljko S, Grazio S, Sokolovic S, Schuurman PR, Mehta AD, Levine YA, Faltys M, Zitnik R, Tracey KJ, Tak PP. Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis. Proc Natl Acad Sci U S A. 2016 Jul 19;113(29):8284-9. doi: 10.1073/pnas.1605635113. Epub 2016 Jul 5.</citation>
    <PMID>27382171</PMID>
  </reference>
  <reference>
    <citation>Thayer JF, Sternberg EM. Neural aspects of immunomodulation: focus on the vagus nerve. Brain Behav Immun. 2010 Nov;24(8):1223-8. doi: 10.1016/j.bbi.2010.07.247. Epub 2010 Jul 30. Review.</citation>
    <PMID>20674737</PMID>
  </reference>
  <reference>
    <citation>Lv H, Zhao YH, Chen JG, Wang DY, Chen H. Vagus Nerve Stimulation for Depression: A Systematic Review. Front Psychol. 2019 Jan 31;10:64. doi: 10.3389/fpsyg.2019.00064. eCollection 2019.</citation>
    <PMID>30766497</PMID>
  </reference>
  <reference>
    <citation>O'Reardon JP, Cristancho P, Peshek AD. Vagus Nerve Stimulation (VNS) and Treatment of Depression: To the Brainstem and Beyond. Psychiatry (Edgmont). 2006 May;3(5):54-63.</citation>
    <PMID>21103178</PMID>
  </reference>
  <reference>
    <citation>Jordana J, Triviño-Salazar JC. Where are the ECDC and the EU-wide responses in the COVID-19 pandemic? Lancet. 2020 May 23;395(10237):1611-1612. doi: 10.1016/S0140-6736(20)31132-6. Epub 2020 May 13.</citation>
    <PMID>32410757</PMID>
  </reference>
  <reference>
    <citation>Zhu S, Wu Y, Zhu CY, Hong WC, Yu ZX, Chen ZK, Chen ZL, Jiang DG, Wang YG. The immediate mental health impacts of the COVID-19 pandemic among people with or without quarantine managements. Brain Behav Immun. 2020 Jul;87:56-58. doi: 10.1016/j.bbi.2020.04.045. Epub 2020 Apr 18.</citation>
    <PMID>32315758</PMID>
  </reference>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>May 29, 2020</study_first_submitted>
  <study_first_submitted_qc>June 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 4, 2020</study_first_posted>
  <last_update_submitted>June 5, 2020</last_update_submitted>
  <last_update_submitted_qc>June 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>COVID19</keyword>
  <keyword>CYTOKINE STORM</keyword>
  <keyword>MEDICAL YOGA PRANAYAMA</keyword>
  <keyword>VAGUS NERVE STIMOLATION</keyword>
  <keyword>MENTAL DISORDER</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronavirus Infections</mesh_term>
    <mesh_term>Severe Acute Respiratory Syndrome</mesh_term>
    <mesh_term>Mental Disorders</mesh_term>
    <mesh_term>Psychotic Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The datasets generated during and/or analysed during the current study will be available upon request within a web_ client structure</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>18 months</ipd_time_frame>
    <ipd_access_criteria>ID and password</ipd_access_criteria>
    <ipd_url>https://ifc.cnr.it</ipd_url>
  </patient_data>
  <study_docs>
    <study_doc>
      <doc_id>guest_1</doc_id>
      <doc_type>Study Protocol</doc_type>
      <doc_url>http://giardinostlucia.it</doc_url>
    </study_doc>
    <study_doc>
      <doc_id>guest_2</doc_id>
      <doc_type>Informed Consent Form</doc_type>
      <doc_url>http://giardinostlucia.it</doc_url>
    </study_doc>
    <study_doc>
      <doc_id>guest_3</doc_id>
      <doc_type>Individual Participant Data Set</doc_type>
      <doc_url>http://giardinostlucia.it</doc_url>
    </study_doc>
  </study_docs>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

